Capital Advisors Ltd. LLC Sells 165 Shares of Colgate-Palmolive (NYSE:CL)

Capital Advisors Ltd. LLC decreased its position in Colgate-Palmolive (NYSE:CL) by 17.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 763 shares of the company’s stock after selling 165 shares during the quarter. Capital Advisors Ltd. LLC’s holdings in Colgate-Palmolive were worth $69,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. D Orazio & Associates Inc. lifted its position in Colgate-Palmolive by 3.9% in the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the last quarter. Fiducient Advisors LLC lifted its position in Colgate-Palmolive by 5.2% in the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after buying an additional 110 shares during the last quarter. Commonwealth Financial Services LLC lifted its position in Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after buying an additional 118 shares during the last quarter. Lantz Financial LLC lifted its position in Colgate-Palmolive by 0.6% in the fourth quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares during the last quarter. Finally, Horizon Kinetics Asset Management LLC lifted its position in Colgate-Palmolive by 4.2% in the third quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock valued at $322,000 after purchasing an additional 124 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of several recent research reports. Morgan Stanley lowered their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Barclays lowered their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Piper Sandler lowered their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $101.16.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $90.10 on Tuesday. The stock has a market cap of $73.12 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 4.20 and a beta of 0.44. The business’s fifty day moving average is $88.88 and its 200 day moving average is $95.73. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the business earned $0.87 EPS. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.22%. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.